Introduction
Congenital hypothyroidism (CH) is characterized by the insufficient production of thyroid hormone usually due to thyroid dysgenesis or thyroid dyshormonogenesis. Therefore, lifelong treatment with thyroxine (T4) is of utmost importance because thyroid hormone not only plays an important role in metabolism but also plays a major role in the development of the central nervous system during prenatal life and the first years after birth. 1 The aim of neonatal CH screening programs is to prevent cerebral damage through early initiation of T4 supplementation.
Early treatment has resulted in remarkable improvement in the neuropsychological functioning of CH patients. [2] [3] [4] Nevertheless, there is ample evidence that CH patients diagnosed by neonatal screening, especially those with severe CH, are still vulnerable to persistent cognitive and motor deficits.
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Although much is written about cognitive and motor development of children with CH, little is known about the daily functioning and quality of life of patients growing up with CH.
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CH may affect the patient's daily life because of the hospital visits, daily T4 administration, need of regular dose adjustments, and sometimes the need of adjuvant medical care such as speech training and physiotherapy. In addition to this, the cognitive and motor problems of CH patients might affect their social life, self-esteem and emotional functioning.
In general literature, there is growing attention for possible late psychological effects in children and young adults with chronic diseases. 12 However, the adjustment of young adults with CH, such as health-related quality of life (HRQoL), developmental tasks, and self-esteem has not been studied thoroughly. HRQoL can be used as an indicator of adjustment, which comprises elements of physical, functional, social and psychological health, as well as the patient's perceived health status and well-being. 13 The fulfilling of age specific developmental tasks and achieving developmental milestones in youth, such as searching for contacts outside the family, or acquisition of independence, referred to as the "course of life" (CoL), are of great importance to adjustment in adult life. 14 A positive self-esteem is a significant factor influencing overall good mental health and psychological well-being, 15;16 and is regarded by major theorists as a basic psychological need. 17 From 2001 until now, we conducted a national study to evaluate whether the changes in the screening procedure and treatment strategy over two decades (e.g., earlier detection, higher initial T4 dose) have led to the improved development of patients with CH. We investigated intellectual and motor outcome and social-emotional functioning in terms of HRQoL of CH patients born in 1981-1982, 1992-1993 and 2002-2004 . The purpose of the present study was to explore the HRQoL, CoL, social demographical outcomes, and self-esteem in young adults with CH born in 1981 and 1982, and compare the results to those of the general (healthy) population.
Furthermore, the study examined the influence of severity of CH on these outcomes.
Patients and methods

Patients
The In 2001, the remaining 124 patients were contacted via their physicians and were asked to participate. A total of 82 patients (66%) gave their written informed consent. To ascertain that patients were euthyroid (i.e. TSH, 0.4-4.0µU/ml) at testing, the most recent measurement of thyroid function before the psychological assessments was evaluated; the T4 supplementation dose was adjusted when TSH was outside its reference range.
Procedure
All patients were asked to complete the questionnaires, at the AMC (except for four, who were tested in their local hospitals), under the supervision of the same psychologist, who was blinded for the patient's medical details. The assistance of the psychologist was restricted to explaining the meaning of difficult words. The description of the non-participants is provided in a previous study. 7 The study protocol was approved by the institutional review board of the AMC.
Measures
TNO-AZL Questionnaire for Adult's Health-Related Quality of Life (TAAQoL)
The 'TNO-AZL (Netherlands Organization for Applied Scientific Research) Questionnaire for Adult's Health-Related Quality of Life' (TAAQoL) is a validated, generic HRQoL questionnaire for subjects 16 years and older. 19 The questionnaire focuses on health problems in the past month, and, if present, the well-being in relation to this health problem is assessed. for details).
The validity and the test-retest reliability of the CoL scales are good. 20 The internal consistencies (Cronbach's alphas) in the population under study were small to good: (1) development of autonomy: CH 0.40, comparison group 0.48; (2) psychosexual development:
CH 0.83, comparison group 0.67; (3) social development: CH 0.76, comparison group 0.71.
Self-Esteem Scale
Self-esteem was assessed with the Rosenberg Self-Esteem Scale (RSE), a self administered, 10-item, 4-point scale with response options ranging from 1 (strongly agree) to 4 (strongly disagree). 22 The scale measures the self-acceptance aspect of self-esteem or the overall sense of being capable, worthwhile, and competent. Possible scores range from 10 to 40. The scoring direction on five negatively phrased items was reversed, so a higher score now is indicative of higher self-esteem. For the study sample, a sufficient Cronbach's alpha coefficient of 0.89 was obtained. A comparison group of 515 young adults aged 18-25 years was available (see Ref. 23 for details).
Statistical analysis
Data were analysed using SPSS version 12.0 (SPSS Inc., Chicago, IL). Before conducting the final analyses several preparation analyses were conducted. Firstly scale scores were computed and missing data imputed on the basis of the guidelines of the questionnaires. The missing data on the TAAQoL and RSE were imputed at scale level. In calculation of the scale scores, one missing item score was allowed for. The missing score is replaced by the mean value of the nonmissing item scores. The missing data on the CoL questionnaire were not imputed. Second, the internal consistencies (Cronbachs alpha) of the scales were calculated, and the distributions of the scale scores were considered.
After the preparatory analyses, univarate analysis of variance (ANOVAs) were conducted to test differences between the CH group and healthy controls on the TAAQoL scales, CoL scales, and RSE, corrected for gender. All CH patients were compared with the norm data, To create a clinically meaningful distinction between young adults that can be considered 'at risk' or 'not at risk' for problems, two groups were formed, based on percentile norms in the healthy population. If this is done for groups classified by age and gender, differences between the CH group and the norm group are accounted for, and groups can be compared. 25 The definition of young adults with problems was based on the value of the 25 th percentile for all domains of the TAAQoL, CoL and the RSE in the norm population. A young adult who scores below the 25 th percentile is placed in the quarter of the most impaired population. To determine whether the CH sample was different from the healthy population, percentages at risk were compared using Chi-square tests (χ 2 -tests).
To gain detailed insight into the CoL of CH patients, differences on item level (milestones)
were also calculated on the social development scale of the CoL questionnaire because there was a significant difference on this scale between the CH and comparison group. χ 2 -tests were conducted at the frequency distributions of the individual items of this scale.
Finally, χ 2 -tests were conducted to investigate differences in educational level (low, middle, and high), a special education at primary school, living situation and marital status. We used a significance level of P<0.01 in order to compensate for multiple testing.
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Results patient characteristics
A total of 82 CH patients (66% of the original cohort) gave their written informed consent, and their initial thyroid hormone levels and treatment modality were recorded. Of this group, 13 patients were excluded from the study because of central CH (n=1), because treatment was never initiated (n=1), an exceptionally late (i.e. >4 years of age) start of treatment (n=5), a discontinuation of treatment at young age (n=4), or because the patients did not return the questionnaires (n=2). The remaining 69 patients, 51% of the original cohort (total CH group),
were classified into two subgroups according to an arbitrarily chosen cutoff level for severity of postnatal hypothyroidism: 'severe CH' with initial T4 <2.3µg/dl (<30 nmol/liter) and 'moderate and mild CH' with initial T4 ≥2.3 µg/dl (≥30 nmol/liter).
The baseline characteristics of the participating CH patients are given in Four groups are presented; the total group, the group of patients who did not participate divided in patients not suitable or not willing to participate and the group of patients who did participate.
For each group, the subdivision according to etiological classification is given. CH n.o.s., CH not otherwise specified. No significant differences were found between the CH patients and the healthy Dutch population on three out of the 11 scales on the TAAQoL (gross motor functioning; sexual functioning; happiness). 
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CoL
The total CH group and the severe CH group scored significantly lower on one scale of the CoL than the comparison group: social development, total CH group: F (1.334)= 6.191, p< 0.013; severe CH group, F (1.302)= 6.557 (table 3). These differences were small: effect size (d)= 0.4.
No differences were found for the autonomy scale and psychosexual development scale.
With respect to the milestones of social development, we found significant differences between the CH patients and the reference group on two out of the twelve milestones (table   4) . A lower percentage of CH patients than of the comparison group had been a member of a sports club for at least 1 year during primary school and secondary school.
No statistically significant differences between CH and the comparison group were found in the numbers of patients still living with their parents or in marital status. In addition, no significant difference was found with respect to current educational level and in patients receiving special education at primary school as compared to the comparison group (table 5).
Self-esteem
CH patients in the total and severe CH group appeared to have a significantly lower self-esteem than the comparison group: total CH group, F (1.572)= 5.224, p< 0.005); and severe CH group: F (1.542)= 8.513, p< 0.004) (table 3). These difference had moderate effect sizes (d= 0.5).
Within-group differences according to severity
There were no significant differences found between the severity groups for HRQoL, CoL and self-esteem (Table 3) . Table 6 shows the percentages of young adults at risk for all impaired HRQoL, CoL and selfesteem domains. χ 2 -tests comparing the CH patients with healthy controls on HRQoL, CoL and self-esteem showed significant differences for six scales of the TAAQoL. The total group of CH patients showed significantly higher percentages of patients at risk for HRQoL than the comparison group on five scales of the TAAQoL (cognitive functioning; social functioning; daily activities; vitality and depressive moods), ranging from 41% to 68%. In the severe group, CH patients were considered at risk for problems on six scales of the TAAQoL (gross motor functioning, cognitive functioning; social functioning; agressiveness; vitality; depressive moods) , ranging from 42% to 70%. In addition, CH patients in the moderate /mild CH group were only considered at risk on two scales of the TAAQoL (sleeping, cognitive functioning), ranging from 54% to 66%. 
Prevalence of young adults with CH at risk
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Quality of life, developmental milestones and self-esteem of young adults with congenital hypothyroidism diagnosed by neonatal screening ¹ Twenty-h percentiles of healthy young adults are not exact 25 %, due to distribution of scale scores. Percentiles approach 25 th , ranging from 18th -31st percentile. *p<0.004 **p<0.0001 Chi-square test in comparison with healthy children.
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Discussion
To our knowledge, this is the first study describing the developmental and HRQOL consequences in early treated young adult patients with CH using validated and reliable instruments. We have shown that having CH does negatively influence the HRQoL, social development and selfesteem. However, the sociodemographical outcomes and their final educational level until now did not differ from that of the normal population.
This study shows that patients with CH born in 1981-1982 do not experience more problems with autonomy development and sexual functioning, and they have similar feelings of happiness as the healthy Dutch population controls. Despite these positive findings, CH has a negative impact on daily life of the patients. They experienced more problems concerning cognitive and social functioning, pain, daily activities, aggressiveness, self-esteem and they appeared to be less vital and more depressed compared with the healthy Dutch population. To add clinical meaning to these differences, we divided the young adults in two groups, one at risk for an impaired HRQoL, CoL and self-esteem and one not at risk. This division shows that young adults with CH, especially in patients with severe CH, are more often at risk for HRQoL impairment. The definition of young adults as being at risk was based on the value of the 25 th percentile of all scales in the norm population. There is no gold standard for good or bad HRQoL, CoL and self-esteem, however, this definition is considered to be a suitable way to differentiate between individuals with higher scale scores from individuals with lower scale scores. 25 The most salient result is that CH patients reported a considerable lower HRQol on the showed that children and young adults with CH scored significantly poorer on overall attention
and had more problems with memory than controls. [26] [27] [28] [29] Our results indicate that problems in cognitive functioning trouble most CH patients and hamper their daily life.
As expected severe CH patients are more at risk for problems with gross motor functioning than patients with moderate/ mild CH. This is consistent with our recent findings that the total CH group born in 1981/1982 had substantial motor problems. 7 This is also in line with the findings on the items of the social development scale of the CoL questionnaire, which showed that CH patients reported a lower level of participation in sport clubs.
Although more significant differences between the severity group and the comparison group than the moderate/mild CH group compared to the healthy population were found, we did not find significant within-group differences on severity for CoL, HRQoL or self-esteem. It may be considered, that the existence of a chronic disease as such, regardless of its severity, influences functioning in daily life.
The negative consequences of CH on the HRQoL, social development, and self-esteem might also be explained by the fact of living with a chronic disease. CH affect the patient's daily life because of the daily T4 administration, the need of regular T4-dose adjustments, frequent T4
and TSH measurements, consciousness of having a chronic disease, and sometimes the need of adjuvant medical care such as speech training and physiotherapy. It is also possible that parents of a child with CH were more protective which resulted in less stimulation of social development.
In addition, the cognitive and motor problems of CH patients may have affected their social life, self esteem and emotional functioning. From this study and our previous study, 7 it is apparent that CH patients seem to be vulnerable in this area. Besides, one has to keep in mind that a suboptimal thyroid hormone state may affect well-being. Whereas the goal of long-term T4 treatment is to maintain euthyroidism, this remains challenging because of the continuous need
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Quality of life, developmental milestones and self-esteem of young adults with congenital hypothyroidism diagnosed by neonatal screening to adapt T4 dose in a growing child and the need of treatment compliance. Recently, it has been shown that differences in FT4 and TSH concentration, even within the reference range, may be a determinant of psychological well-being in treated hypothyroid patients. 30 The strength of our study is that all patients were treated by pediatricians who followed the national guidelines and that at psychological assessments, all patients had plasma TSH concentrations within the reference range.
There are some limitations in the present study that need to be mentioned. First, 'course of life' encompasses more than the achievement of developmental milestones and encompasses more accomplishment during childhood than we have been able to assess with the questionnaire. It is the only (Dutch) questionnaire concerning this issue and test-retest reliability has proved to be satisfactory. 20 However, the internal consistency of the Autonomy scale is small, probably because the items concern diverging aspects of autonomy. The disadvantage of using scales with low internal consistency is that detecting differences between groups is more difficult.
Considering our findings, this did not apply. Second, CH patients described in this study differ from more recently diagnosed patients because the screening and treatment strategy has been changed over the past two decades (e.g., earlier detection, higher initial T4 dose). Therefore, we need to be cautious in generalizing our results towards more recently diagnosed CH patients.
In addition, it is important to investigate the HRQoL, CoL, social demographic outcomes and self-esteem in more recent cohorts. Another limitation is the loss of subjects from the original cohort, which restricts the representativity of the current sample. Besides, we have no information about the socio-economic status, we clarified the etiology of both the excluded patients and the patients not willing to participate (table 1) . At last we should take notice of the use of different questionnaires of which norm data were acquired in different studies. This should be taken into account when comparing the data.
The findings of the study have implications for future research. It is important to study cognitive functioning in more detail, e.g. to determine attention and memory of CH patients.
Intervention programs that improve memory and attention functioning might thereafter be offered to particular individuals.
A remarkable result in the present study was that CH patients were not different in educational level as compared to controls. Most patients were 21 years of age at time of testing. Therefore, most patients have not yet completed their education at the moment of testing. For that reason, it is unclear whether CH patients will be able to function on the same level in society (after completion of their education) as their healthy peers. For future research this is an important aspect to consider when testing adult patients, who already fulfil a certain role in society.
Because CH patients appeared to be less vital and more depressed compared to the healthy Dutch population, it seems interesting to study the relation between CH, and anxiety and depression in more detail. From a developmental, psychological point of view, the fulfilling of age-specific developmental tasks in childhood is of great importance for adjustment in adult life. 14;31 For this reason it is important to direct future research on the predictors of a hampered social development, in order to be able to detect the children and adolescents who are at risk at an early stage.
Communication about problems in clinical practice should be studied in more detail in order to get insight whether problems are adequately assessed. In summary, we conclude that young adults with CH reported a lower HRQoL and had a lower self-esteem compared with healthy peers. CH patients also had a delayed social development. 
